The role of the gut microbiota in NAFLD

C Leung, L Rivera, JB Furness… - … reviews Gastroenterology & …, 2016 - nature.com
NAFLD is now the most common cause of liver disease in Western countries. This Review
explores the links between NAFLD, the metabolic syndrome, dysbiosis, poor diet and gut …

A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease

JZK Toh, XH Pan, PWL Tay, CH Ng, JN Yong… - Clinical …, 2022 - Elsevier
Background & Aims Cardiovascular disease remains the leading cause of death in patients
with nonalcoholic fatty liver disease (NAFLD). Studies examining the association of coronary …

Epidemiology and natural history of nonalcoholic fatty liver disease

SK Satapathy, AJ Sanyal - Seminars in liver disease, 2015 - thieme-connect.com
The epidemic of obesity has resulted in a parallel incremental burden of nonalcoholic fatty
liver disease (NAFLD) worldwide. Nonalcoholic fatty liver disease includes a spectrum of …

Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy

SB Reeder, I Cruite, G Hamilton… - Journal of magnetic …, 2011 - Wiley Online Library
Hepatic steatosis is characterized by abnormal and excessive accumulation of lipids within
hepatocytes. It is an important feature of diffuse liver disease, and the histological hallmark …

The medical risks of obesity

X Pi-Sunyer - Postgraduate medicine, 2009 - Taylor & Francis
Obesity is at epidemic proportions in the United States and in other developed and
developing countries. The prevalence of obesity is increasing not only in adults, but …

[HTML][HTML] Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis

HM Parker, NA Johnson, CA Burdon, JS Cohn… - Journal of …, 2012 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is a frequent accompaniment of obesity and
insulin resistance. With the prevalence approaching 85% in obese populations, new …

[PDF][PDF] Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver‐related mortality

ZM Younossi, M Stepanova, N Rafiq, H Makhlouf… - …, 2011 - Wiley Online Library
Since the initial description of nonalcoholic steatohepatitis (NASH), several sets of
pathologic criteria for its diagnosis have been proposed. However, their interprotocol …

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

LS Bhatia, NP Curzen, PC Calder… - European heart …, 2012 - academic.oup.com
Non-alcoholic fatty liver disease (NAFLD) affects up to a third of the population worldwide
and may confer increased cardiometabolic risk with consequent adverse cardiovascular …

A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?

ET Oni, AS Agatston, MJ Blaha, J Fialkow, R Cury… - Atherosclerosis, 2013 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) is an emerging disease and a
leading cause of chronic liver disease. The prevalence in the general population is …

Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)

P Golabi, M Otgonsuren, L de Avila, M Sayiner… - Medicine, 2018 - journals.lww.com
Components of metabolic syndrome increase the risk of mortal... : Medicine Components of
metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD) …